MedPath

Siegfried Holding AG

Siegfried Holding AG logo
🇨🇭Switzerland
Ownership
Public
Established
1873-01-01
Employees
3.8K
Market Cap
$5.6B
Website
http://www.siegfried.ch

FDA Approves ILUVIEN Label Expansion for Chronic Non-Infectious Uveitis Treatment

The FDA has approved an expanded label for ILUVIEN (fluocinolone acetonide intravitreal implant) to include treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, in addition to its existing diabetic macular edema indication.

© Copyright 2025. All Rights Reserved by MedPath